These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28853128)

  • 1. Eliminating hepatitis from the Eastern Mediterranean Region.
    Fikri M
    East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Needlestick injury--risk and prevention of blood borne infections].
    Georgi AK; Ruef C; Rampini SK
    Praxis (Bern 1994); 2009 Oct; 98(20):1119-27, 1129; quiz 1128. PubMed ID: 19809974
    [No Abstract]   [Full Text] [Related]  

  • 3. Eliminating hepatitis C.
    Burki T
    Lancet Infect Dis; 2019 Mar; 19(3):246-247. PubMed ID: 30833063
    [No Abstract]   [Full Text] [Related]  

  • 4. Countdown to 2030: eliminating hepatitis B disease, China.
    Liu J; Liang W; Jing W; Liu M
    Bull World Health Organ; 2019 Mar; 97(3):230-238. PubMed ID: 30992636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rx for B and C.
    Gibbs WW
    Sci Am; 1999 Mar; 280(3):17-20. PubMed ID: 10048231
    [No Abstract]   [Full Text] [Related]  

  • 6. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradicating the Viral Triad in Hemodialysis Units.
    Adams B; Yee J
    Adv Chronic Kidney Dis; 2019 May; 26(3):157-161. PubMed ID: 31202386
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward.
    Qureshi H
    East Mediterr Health J; 2013 Jul; 19(7):585-6. PubMed ID: 24975300
    [No Abstract]   [Full Text] [Related]  

  • 9. The BASHH HIV Special Interest Group (SIG).
    Waters L; Edwards S
    Sex Transm Infect; 2015 Feb; 91(1):6. PubMed ID: 25609464
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights from the 60th Annual Meeting of the AASLD.
    Mayor S
    Lancet Infect Dis; 2010 Jan; 10(1):8. PubMed ID: 20162852
    [No Abstract]   [Full Text] [Related]  

  • 11. New WHO guidance for country validation of viral hepatitis B and C elimination.
    Easterbrook P; Luhmann N; Newman M; Walsh N; Lesi O; Doherty M
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):778-780. PubMed ID: 34384530
    [No Abstract]   [Full Text] [Related]  

  • 12. [Status of hepatitis C in Guangzhou from 2005 to 2008].
    Lin CS; Zhao ZX; Zhang XH; Guo XY; Li TG; Chong YT; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):63-4. PubMed ID: 20128974
    [No Abstract]   [Full Text] [Related]  

  • 13. [HVB and HVC infections in nephrology].
    Pol S
    Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 15. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral hepatitis: towards the eradication of HCV and a cure for HBV.
    Marcellin P
    Liver Int; 2016 Jan; 36 Suppl 1():5-6. PubMed ID: 26725890
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
    Targhetta C; Cabras MG; Angelucci E
    Haematologica; 2008 Nov; 93(11):e66. PubMed ID: 18978292
    [No Abstract]   [Full Text] [Related]  

  • 18. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Mar; 139(13):655-9. PubMed ID: 24648178
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis, HIV, and the dermatologist: a risk review.
    Kiene K; Hsu B; Rowe D; Carruthers A
    J Am Acad Dermatol; 1994 Jan; 30(1):108-15. PubMed ID: 8277009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.